Peritoneal damage by peritoneal dialysis solutions

Clinical and Experimental Nephrology

Volumn 12, Issue 4, 2008, Pages 243-249

  Ito, Takafumi ^a   Yorioka, Noriaki ^b  

^a SHIMANE UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; CAPD; Coagulation and fibrinolysis factors; Glucose degradation products; High glucose; HPMCs; Lactate; pH; Renin angiotensin system; TGF 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; GLUCOSE POLYMER; ICODEXTRIN; LACTIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1;

BIOCOMPATIBILITY; BLOOD CLOTTING; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; EXPERIMENTAL STUDY; FIBRINOLYSIS; FIBROSIS; HUMAN; NONHUMAN; OSMOLALITY; PERITONEAL DAMAGE; PERITONEAL DISEASE; PERITONEAL FIBROSIS; PERITONEAL SCLEROSIS; PERITONEUM; PH; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SOLUTION AND SOLUBILITY;

HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; SCLEROSIS;

EID: 47649089043     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-008-0032-y     Document Type: Review

References (84)

1. JW Dobbie 1989 Morphology of the peritoneum in CAPD Blood Purif 7 74 85
2. H Nakamoto Y Kawaguchi H Suzuki 2002 Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan Adv Perit Dial 18 119 23
3. A Jörres GM Gahl U Frei 1994 Peritoneal dialysis fluid biocompatibility: does it really matter? Kidney Int 48 79 86
4. J Rubin GA Herrera D Collins 1991 An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis Am J Kidney Dis 18 97 102
5. K Honda K Nitta S Horita W Yumura H Nihei R Nagai 1999 Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration Nephrol Dial Transplant 14 1541 9
6. S Mortier AS De Vriese J Van de Voorde TP Schaub J Passlick-Deetjen NH Lameire 2002 Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products J Am Soc Nephrol 13 480 9
7. TY Wong CC Szeto KB Lai CW Lam KN Lai PK Li 2000 Longitudinal study of peritoneal membrane function in continuous ambulatory peritoneal dialysis: relationship with peritonitis and fibrosing factors Perit Dial Int 20 679 85
8. SJ Davies 2006 Exploring new evidence of the clinical benefits of icodextrin solutions Nephrol Dial Transplant 21 ii47 50
9. JD Williams N Topley KJ Craig RK Mackenzie M Pischetsrider C Lage 2004 The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane Kidney Int 66 408 18
10. HY Lee HC Park BJ Seo JY Do SR Yun HY Song 2005 Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (balance) Perit Dial Int 25 248 55
11. R Gokal 1993 Recent perspectives on peritoneal dialysis Contrib Nephrol 102 98 109
12. ME Rosenberg 1999 Peritoneal dialysis: diabetes of the peritoneal cavity J Lab Clin Med 134 103 4
13. TYH Wong AO Phillips J Witowski N Topley 2003 Glucose-mediated induction of TGF-β and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent Kidney Int 63 1404 16
14. K Kumano B Schiller JT Hjelle J Moran 1996 Effect of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells Blood Purif 14 165 9
15. L Gotloib V Waisbrut A Shostak R Kushnier 1995 Acute and long-term change observed in imprints of mouse mesothelium exposed to glucose enriched, lactate buffered dialysis solution Nephron 70 466 77
16. T Ito N Yorioka M Yamamoto K Kataoka M Yamakido 2000 Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells J Am Soc Nephrol 11 1969 79
17. A Breborowicz H Rodela DG Oreopoulos 1992 Toxicity of osmotic solutes on human mesothelial cells in vitro Kidney Int 41 1280 5
18. EW Gabrielson BI Gerwin CC Harris AB Roberts MB Sporn JF Lechner 1988 Stimulation of DNA synthesis in cultured primary human mesothelial cells by specific growth factors FASEB J 2 2717 21
19. K Takazoe M Nakayama Y Utsunomiya N Osaka H Hasegawa H Kubo 1997 Detection of TGF-β1 in CAPD effluents Clin Nephrol 47 67 9
20. T Wang YG Chen RG Ye SL Li HQ Li YX Chen 1995 Effect of glucose on TGF-β1 expression in peritoneal mesothelial cells Adv Perit Dial 11 7 10
21. KN Lai KB Lai CC Szeto CWK Lam JCK Leung 1999 Growth factors in continuous ambulatory peritoneal dialysis effluent Am J Nephrol 19 416 22
22. PJ Margetts P Bonniaud L Liu CM Hoff CJ Holmes JA West-Mays 2005 Transient overexpression of TGF-β1 induces epithelial mesenchymal transition in the rodent peritoneum J Am Soc Nephrol 16 425 36
23. PJ Margetts M Kolb T Galt CM Hoff TR Shockley J Gauldie 2001 Gene transfer of transforming growth factor-β1 to the rat peritoneum: effect on membrane function J Am Soc Nephrol 12 2029 39
24. S Combet T Miyata P Moulin D Pouthier E Goffin O Devuyst 2000 Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long term peritoneal dialysis J Am Soc Nephrol 11 717 28
25. PJ Thoralley C Johal D Dobler R Babaei-Jadidi N Ahmed 2005 Concentration of glucose degradation products, glyoxal, methylglyoxal and 3-deoxyglucosone, in current generation peritoneal dialysis fluids determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) J Am Soc Nephrol 16 268A
26. JA Nagy 1996 Peritoneal membrane morphology and function Kidney Int 56 S2 11
27. M Simionescu N Simionescu 1977 Organization of cell junctions in the peritoneal mesothelium J Cell Biol 74 98 110
28. JA Nagy RW Jackman 1998 Anatomy and physiology of the peritoneal membrane Semin Dial 11 49 56
29. M Ruiz-Ortega O Lorenzo Y Suzuki M Ruperez J Egido 2001 Proinflammatory actions of angiotensins Curr Opin Nephrol Hypertens 10 321 9
30. G Wolf EG Neilson 1993 Angiotensin II as a renal growth factor J Am Soc Nephrol 3 1531 40
31. SA Mezzano M Ruiz-Ortega J Egido 2001 Angiotensin II and renal fibrosis Hypertension 38 635 58
32. F Bouzegrhane G Thibault 2002 Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovasc Res 53 304 12
33. S Duman AI Gunal S Sen G Asci M Ozkahya E Terzioglu 2001 Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int 21 219 24
34. R Singh AK Singh N Alavi DJ Leehey 2003 Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose J Am Soc Nephrol 14 873 80
35. R Singh N Alavi AK Singh DJ Leehey 1999 Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation Diabetes 48 2066 73
36. A Malhotra BP Kang S Cheung D Opawumi LG Meggs 2001 Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin Diabetes 50 1918 26
37. H Noh H Ha MR Yu YO Kim JH Kim HB Lee 2005 Angiotensin II mediates high glucose-induced TGF-β1 and fibronectin upregulation in HPMC through reactive oxygen species Perit Dial Int 25 38 47
38. Y Kyuden T Ito T Masaki N Yorioka N Kohno 2005 TGF-β1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells Perit Dial Int 25 483 91
39. K Kiribayashi T Masaki T Naito T Ogawa T Ito N Yorioka 2005 Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK 1/2 and p38 MAPK Kidney Int 67 1126 35
40. M Sauter D Clemens M Wörnle T Mussack R Ladurner T Sitter 2006 ACE inhibitor and Ata-receptor blocker attenuate the production of VEGF in mesothelial cells Perit Dial Int 22 167 72
41. T Sitter M Spannag H Schiffi E Held VWM van Hinsbergh T Kooistra 1995 Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients. The role of mesothelial cells Nephrol Dial Transplant 10 677 83
42. JC Shao N Yorioka Y Nishida M Yamakido 1999 Effect of pH and glucose on cultured human peritoneal mesothelial cells Scand J Urol Nephrol 33 248 56
43. Sitter T, Mandl-Weber S, Wornle M, Haslinger B, Goedde M, Kooistra T. D-Glucose increases the synthesis of tissue-type plasminogen activator (t-PA) in human peritoneal mesothelial cells. Thromb Haemost. 1999;82:1171-6.
44. T Sitter K Toet H Fricke H Schffi E Held T Kooistra 1996 Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators Am J Physiol 271 R1256 63
45. M Geoddle T Sitter H Schiffl U Bechtel W Schramm M Spannagl 1997 Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients Perit Dial Int 17 121 4
46. C Higuchi Y Tanihata H Nishimura T Naito T Sanaka 2005 Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum Ther Apher Dial 9 173 81
47. Y Hung N Noble 2005 An unexpected role of plasminogen activator inhibitor-type 1 (PAI-1) in renal fibrosis Kidney Int 67 2502 3
48. J Yang RW Shultz WM Mars RE Wegner Y Li C Dai 2002 Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy J Clin Invest 110 1525 38
49. Katsutani M, Ito T, Masaki T, Kohno N, Yorioka N. Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK 1/2. Ther Apher Dial. 2007;11:94-100.
50. CD Mistry NP Mallick R Gokal 1987 Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchange Lancet ii 178 82
51. CW DeFijter HA Verbrugh LP Oe E Heezius AJ Donker J Verhoef 1993 Biocompatibility of a glucose polymer-containing peritoneal dialysis fluid Am J Kidney Dis 21 411 8
52. CD Mistry R Gokal E Peers the MIDAS Study Group 1994 A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD Kidney Int 46 496 503
53. S Thomas U Schnek FP Fischer T Metang J Passlick-Deetjen U Kuhlmann 1007 In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity Am J Kidney Dis 29 246 53
54. T Ito N Yorioka Y Kyuden Y Asakimori K Kiribayashi T Ogawa 2003 Effect of glucose polymer on the intercellular junctions of cultured human peritoneal mesothelial cells Nephron Clin Pract 93 c97 105
55. Y Ueda T Miyata E Goffin A Yoshino R Inagi Y Ishibashi 2000 Effect of dwell time on carbonyl stress using icodextirn and amino acid peritoneal dialysis fluids Kidney Int 58 2518 24
56. R Kuriyama A Tranaeus T Ikegami 2006 Icodextrin reduces mortality and the drop-out rate in Japanese peritoneal dialysis patients Adv Perit Dial 22 108 10
57. SJ Davies EA Brown NE Frandsen AS Rodrigues A Rodriguez-Carmona A Vychytil 2005 Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription Kidney Int 67 1609 15
58. N Topley D Kaur MM Peterson A Jörres J Passlick-Deetjen GA Coles 1996 Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cells and neutrophil function Kidney Int 49 1447 56
59. J Floge E Eng V Lindner CE Alpers BA Young MA Reidy 1992 Rat glomerular mesangial cells synthesize basic fibroblast growth factor: release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis J Clin Invest 90 2362 9
60. F Strutz M Zeisberg B Hemmerlein B Sattler K Hummel V Becker 2000 Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation Kidney Int 57 1521 38
61. K Jinno M Tanimizu I Hyodo F Kurimoto T Yamashita 1997 Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease J Gastroenterol 32 119 21
62. S Ogata T Naito N Yorioka K Kiribayashi M Kuratsune N Kohno 2004 Effect of lactate and bicarbonate on human peritoneal mesothelial cells, fibroblasts and vascular endothelial cells, and the role of basic fibroblast growth factor Nephrol Dial Transplant. 19 2831 7
63. N Topley HMM Alobaidi M Davies GA Coles JD Williams D Lloyd 1988 The effects of dialysate on peritoneal phagocyte oxidative metabolism Kidney Int 34 404 1
64. Coles GA, Lewis SL, Williams JD. Host defence and effects of solutions on peritoneal cells. In: Gokal R, Nolph KD, editors. Textbook of peritoneal dialysis. The Netherlands: Kluwer Academic Publishers, 1994, p. 503-8.
65. JW Dobbie 1992 Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis Perit Dial Int 12 14 27
66. AP Wieslander PT Kjellstrand B Rippe 1995 Heat sterilization of glucose-containing fluids for peritoneal dialysis: biological consequences of chemical alterations Perit Dial Int 15 S52 9
67. ε-(carboxymethyl) lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis Biochem Biophys Res Commun 980 1408 14
68. P Kjellstrand M Erixon A Wieslander T Linden E Martinson 2004 Temperature: the single most important factor for degradation of glucose fluids during storage Perit Dial Int 24 385 91
69. M Erixon T Linden P Kjellstrand O Carlsson M Ernebrant F Gunita 2004 PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization Perit Dial Int 24 392 8
70. AP Wieslander MK Nordin E Martinson PT Kjellstrand UC Boberg 1993 Heat-sterilized PD fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes Clin Nephrol 39 343 9
71. J Witowski K Korybalska J Wisniewska A Breborowicz GM Gahl U Fei 2000 Effects of glucose degradation products on human peritoneal mesothelial cell function J Am Soc Nephrol 11 729 39
72. R Inagi T Miyata T Yamamoto D Suzuki K Urakami A Saito 1999 Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis FEBS Lett 463 260 4
73. JCK Leung LYY Chan FFK Li SCW Tang KW Chan TM Chan 2005 Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF Nephrol Dial Transplant 20 1336 49
74. H Shimizu Y Ishibashi T Kumagai S Kaname T Fujita K Sai 2007 Long-term effect of peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration on peritoneum: a case report Perit Dial Int 27 92 4
75. ε- (carboxymethyl) lysine is increased in uremia Kidney Int 52 1064 7
76. MA Freidlander YC Wu VM Monnier 1994 Kinetics of formation of advanced glycosylation end products (AGEs) in peritoneal dialysis (PD) J Am Soc Nephrol 5 A447
77. M Nakayama Y Kawaguchi K Yamada T Hasegawa K Takazoe N Katoh 1997 Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD Kidney Int 51 182 6
78. Y Nishida JC Shao K Kiribayashi C Nakamura N Yorioka 1998 Advanced glycation end-products reduce the viability of human peritoneal mesothelial cells Nephron 80 477 8
79. S Ogata N Yorioka Y Nishida JC Shao M Yamakido 2000 Expression of receptor for advanced glycation end product mRNA by human peritoneal mesothelial cells Nephron 86 245 6
80. S Mandl-Weber CD Cohen B Haslinger M Kretzler T Sitter 2002 Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells Kidney Int 61 570 8
81. AG Welten CG Schalkwijk PM ter Wee S Meijer J van den Born RJ Beelen 2003 Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response Perit Dial Int 23 213 21
82. E Boulanger MP Wautier P Gane C Mariette O Devuyst JL Wautier 2004 The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxidation products Nephrol Dial Transplant 19 2208 16
83. ASD Vriese RG Tilton S Mortier NH. Lameire 2006 Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uremia Nephrol Dial Transplant 21 2549 55
84. S Nakamura T Tachikawa K Tobita S Miyazaki S Sakai T Morita 2003 Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients Am J Kidney Dis 41 S61 7